D.E. Shaw & Co’s Immunomedics Inc IMMU Stock Holding History

D.E. Shaw & Co’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-93,200	Closed	-$3.3M	–	4332
2020 Q2	$3.3M	Buy	+93,200	New	+$2.72M	﹤0.01%	2003
2019 Q1	–	Sell	-60,000	Closed	-$856K	–	4057
2018 Q4	$856K	Hold	60,000	–	–	﹤0.01%	2762
2018 Q3	$1.25M	Hold	60,000	–	–	﹤0.01%	2535
2018 Q2	$1.42M	Hold	60,000	–	–	﹤0.01%	2466
2018 Q1	$877K	Hold	60,000	–	–	﹤0.01%	2579
2017 Q4	$970K	Buy	+60,000	New	+$708K	﹤0.01%	2592

D.E. Shaw & Co's IMMU Position: Q4 2020 in Review

D.E. Shaw & Co sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 1,514,427 shares — an estimated $129M sold.

D.E. Shaw & Co first reported a position in IMMU in Q1 2014 and held it in 21 quarters. The position peaked at $129M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

D.E. Shaw & Co reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
D.E. Shaw & Co sold 1,514,427 Immunomedics Inc shares in Q4 2020, an estimated $129M.
D.E. Shaw & Co first reported a position in Immunomedics Inc in Q1 2014 and held it in 21 quarters.
D.E. Shaw & Co's Immunomedics Inc position peaked at $129M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on D.E. Shaw & Co's 13F filing for Q4 2020, filed 16 Feb 2021.